Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $1.41 on revenue of $1.09B. Analysts polled by Investing.com forecast EPS of $1.22 on revenue of $1.04B. That compared to EPS of $1.07 on revenue of $921M in the same period a year earlier. The company had reported EPS of $1.38 on revenue of $1.09B in the previous quarter.
Edwards Lifesciences shares gained 6.61% to trade at $240.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 46.98%, outperforming the S&P 500 which is up 21.3% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Novartis ADR earnings beat analyst's expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. Investing.com analysts expected EPS of $1.33 on revenue of $11.71B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar